This study identifies a positive correlation between a higher PD-L1 expression measured as a CPS score (the combined measure on tumor cells, lymphocytes and macrophages) ≥10 and the ORR, while previous reported studies have assessed PD-L1 only on tumor cells and did not show any correlation with efficacy [36,37]. This evidence concerns the gene CD274 and neoplasm.